Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8846896 Methods of preparing substituted nucleotide analogs

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jamison Rose0

Cavan McKeon0

Jyanwei Liu0

Leonid Beigelman0

Luigi Anzalone0

Shereen Ibrahim0

Vladimir Serebryany0

Young Chun Jung0

Date of Patent

September 30, 2014

0

Patent Application Number

137939000

Date Filed

March 11, 2013

0

Patent Citations Received

US Patent 11975016 2′-substituted-N

0

US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

0

US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

0

US Patent 11690860 Treatment of HCV infected patients with cirrhosis

0

US Patent 11707480 Highly active compounds against COVID-19

0

Patent Primary Examiner

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8846896 Methods of preparing substituted nucleotide analogs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool